Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06670443

Electrical Stimulation for Respiratory and Leg Muscles Impact on COPD Patients

Electrical Stimulation for Respiratory and Leg Muscles Impact on Pulmonary Function and Leg Restless Syndrome in COPD Patients

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Cairo University · Academic / Other
Sex
All
Age
40 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Electrical neuromuscular stimulation electrode patches will be applied over the intercostal respiratory muscles and leg muscles In addition to conventional pulmonary rehabilitation

Detailed description

Intervention group: active NMES (350 μs pulses - 50 Hz frequency) will be applied at the lower third of the thigh, just above the patella, and the proximal electrode 5-10 cm below the anterior superior iliac spine for quadriceps muscle stimulation, and for intercostal muscles stimulation, NMES will be bilaterally, parallel to the ribs, in the intercostal space. The proximal electrode will be positioned close to the sternum, and the distal electrode laterally, close to the midaxillary line. In addition to conventional pulmonary rehabilitation program that comprised diaphragmatic and pursed lips breathing. control group: placebo NMES at the same points in addition to the same conventional pulmonary rehabilitation program

Conditions

Interventions

TypeNameDescription
DEVICEexperimental groupElectrical neuromuscular stimulation electrode patches will be applied over the intercostal respiratory muscles and leg muscles (placed superficially just below each knee, over the head of the fibula, in close proximity to the common peroneal nerve).
DEVICEcontrol groupPlacebo electrical neuromuscular stimulation electrode patches will be applied over the intercostal respiratory muscles and leg muscles (placed superficially just below each knee, over the head of the fibula, in close proximity to the common peroneal nerve).

Timeline

Start date
2025-01-10
Primary completion
2025-11-30
Completion
2025-12-30
First posted
2024-11-01
Last updated
2025-09-15

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT06670443. Inclusion in this directory is not an endorsement.